Feed/Investors/Ikarian Capital

Ikarian Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Venture capitalDallas, TX 75201ikariancapital.comSince 2026-11-11

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$105M

across 1 round

LATEST ROUND

Series B · $105M · 2026-11-11

CO-INVESTORS

named beside it

Rounds

The rounds this investor is named on, who it invests beside, and where it shows up.

A clinical-stage biotechnology company focused on transforming neuropsychiatric care through selective allosteric modulation

Series B$105M2026-11-1125

Company	Round	Amount	Announced	Role
Neurosterix A clinical-stage biotechnology company focused on transforming neuropsychiatric care through selective allosteric modulation	Series B Verified against 1 of 25 sources	$105M	2026-11-11	[ PART ]